Segment Information (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Schedule of Significant Expense Categories Provided to CODM

The following table is representative of the significant expense categories regularly provided to the CODM when managing the Company’s single reportable segment (in thousands):


		Three Months Ended March 31,
		2026				2025
Revenues(1)		$	398			$	381
Less:
Cost of revenues			134				106
R&D costs(2)			572				485
G&A costs(3)			1,685				1,400
Personnel costs(4)			2,438				3,023
Other segment items(5)			305				378
Net loss		$	(4,736	)		$	(5,011	)

(1) Includes Contract Manufacturing and Clinical Trial revenue

(2) Includes Clinical Development, Research & Discovery, CMC

(3) Includes Executive, Finance, Legal, Business Operations

(4) Includes compensation, benefits and equity-based compensation

(5) Includes depreciation and amortization, (interest income) and other specific charges